Sophie Billioti de Gage

EPI-PHARE (French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)), Saint-Denis, France
Saint-Denis, France

Disclosure information not submitted.

Presentation(s):

• 4F-01 - Sociodemographic and birth characteristics associated with initiation of recombinant growth hormone treatment in children: a nationwide study from 2010 to 2023

  Monday, August 25, 2025
  4:15 PM - 4:30 PM ET